Events Archives - Relaxera

European Society of Cardiology (ESC) Heart Failure Congress 2026 in Barcelona

Marion Michaelis — Wed, 06 May 2026 12:13:43 +0000

Heart Failure 2026, together with World Congress of Acute Heart Failure, organised by the Heart Failure Association of ESC, takes place May 9 – May 12, 2026 in Barcelona, Spain.
The conference provides breakthrough therapies, novel devices and digital health solutions and we are going to present the concept of Relaxin-2 therapy in HFpEF at the hub of “Future Frontiers in Heart Failure”.

Thomas Bernd Dschietzig is going to attend and present – feel free to connect with us for an on-site meeting.

The post European Society of Cardiology (ESC) Heart Failure Congress 2026 in Barcelona appeared first on Relaxera.

Cardiology World Conference

Marion Michaelis — Wed, 04 Jun 2025 17:29:14 +0000

The “6th Edition of Cardiology World Conference” (Cardio 2025) takes place in London, UK and Virtually, from September 15-17, 2025.
The conference, with its overarching theme of “Advancing Heart Health: Breakthroughs in Cardiology” covers a comprehensive range of topics, including cardiovascular diseases and disorders, advanced imaging techniques such as echocardiography and cardiac MRI, and innovative treatments for heart failure and myocardial infarction.

Relaxera’s CEO Thomas Bernd Dschietzig is giving a keynote presentation, titled

“The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF”

The presentation provides animal study data about relaxin-2 reversing left atrial enlargement, fibrosis and DD. In summary, hRlx-2 is highly effective as a candidate therapy for HFpEF. A phase-II clinical trial in HFpEF/HFmrEF patients will start in late 2025.

The post Cardiology World Conference appeared first on Relaxera.

European Society of Cardiology (ESC) Congress 2025 in Madrid

Marion Michaelis — Fri, 30 May 2025 11:08:38 +0000

ESC Congress 2025 together with World Congress of Cardiology

Friday, 29 August – Monday, 01 September 2025
Madrid – Spain

The 2025 ESC Congress is a special edition as it comes together with the World Congress of Cardiology.
The spotlight theme is ‘Global Health,’ meaning ‘Cardiology Beyond Borders’, and therefore emphasising the evolving role of cardiovascular disease within the broader global health landscape. The Scientific Programme offers a global perspective — both geographically and across the full spectrum of cardiology.

Relaxera team is going to attend – feel free to connect with us for an on-site meeting.

The post European Society of Cardiology (ESC) Congress 2025 in Madrid appeared first on Relaxera.

The 21st Annual Congress of International Drug Discovery Science and Technology

Marion Michaelis — Wed, 20 Nov 2024 10:54:35 +0000

The Annual Congress of International Drug Discovery Science & Technology (IDDST), initiated from 2003, has attracted more than 10,000 participants from over 50 countries and regions in the previous 20 years.

The 21^st IDDST (Europe), June 18 – 20, 2025 in Stockholm, will host leading scientists from the academia and outstanding international experts from industry worldwide, to discuss the latest developments in drug discovery and therapy. The program will offer complete updates of recent developments and present the latest results in the remarkable separate tracks. Main idea and target is to stimulate new creative ideas to translate new discoveries into better practice and application.

In session IDDST 01, June 18: Breaking Research in Drug Discovery

our colaboration partner, Prof. Dr. Guy Salama from Pittsburgh Medical University, will be giving a talk about the latest relaxin-2 results in heart failure with preserved ejection fraction (HFpEF), titled “Daily injections of Relaxin 2, its Pharmacokinetics and Remodeling of Rat Hearts with Heart Failure with preserved Ejection Fraction (HFpEF)”.

In session IDDST 07, June 20: Novel Biotherapies, Natural Products & Traditional Medicine

The CEO and chairman of Relaxera, Prof. Thomas Bernd Dschietzig will give a keynote presentation on relaxin-2: “Human relaxin-2 – a natural Hormone holds Promise to tackle the HFpEF Pandemic”.

Information about the conference and the program is available online.

Venue: Clarion Hotel Stockholm, Sweden

Address: Ringvägen 98, 104 60, Stockholm, Sweden

The post The 21st Annual Congress of International Drug Discovery Science and Technology appeared first on Relaxera.

3rd International Heart Congress 2025

Marion Michaelis — Fri, 15 Nov 2024 13:18:17 +0000

The congress takes place 2025 in Rome, Italy, from June 5 – 7.

The most important aspect of this congress is bridging science, innovation, and patient care with the focus on heart health.
The scientific sessions bring together experts from the fields of basic research, translational medicine, pharma R&D, and patient care in order to help to improve cardiovascular outcomes.

Relaxera’s CEO and chairman Thomas Bernd Dschietzig is member of the scientific committee and gives a keynote presentation about “The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF” – listen here.

The full conference program you can find here.

Venue Address:
NH Villa Carpegna
Via Pio IV, 6, 00165 Roma RM, Italy

The post 3rd International Heart Congress 2025 appeared first on Relaxera.

Cardiology World Conference CARDIO 2024

Marion Michaelis — Fri, 15 Nov 2024 12:46:27 +0000

The Cardiology World Conference CARDIO 2024 takes place September 5 – 7, 2024, in Madrid, Spain.

The lecture of Thomas Bernd Dschietzig is about treatment of HFpEF and focuses on pre-clinical experiments and results with relaxin-2, explaining the bolus therapy and the signalling portfolio of the native peptide.
Relaxin-2 delivery reverses diastolic dysfunction, arrhythmia susceptibility, inflammation, and excess fibrosis.
Get a summary of the presentation here an view the whole presentation using this youtube link.

Relaxera is currently preparing a phase II clinical trial in HFpEF.

The post Cardiology World Conference CARDIO 2024 appeared first on Relaxera.

D-A-C-H-Region Congress “Heart Failure”

Marion Michaelis — Fri, 16 Jun 2023 12:01:13 +0000

The Heart Failure Congress takes place September 28 – 30, 2023, in Göttingen, Germany.

The lectures focus on heart failure treatment options, HFpEF, on electrophysiology, diagnostics, operative and intervention heart failure treatment and additional with a view on several comorbidities.

On September 28, the session “Pipeline for the therapy of heart failure” (at 1 pm) includes a presentation by Thomas Dschietzig about relaxin-2 as treatment option.

The post D-A-C-H-Region Congress “Heart Failure” appeared first on Relaxera.

9th International Conference on Relaxin and Related Peptides

Marion Michaelis — Fri, 16 Jun 2023 11:50:04 +0000

Relaxera is supporting and attending the 9th International Conference on Relaxin and Related Peptides.

Featured presenters cover all aspects of basic biology and physiology, plus potential clinical applications of relaxin and related peptides.

One of our contributions will be the chairing of the session “Circulatory and Vasculatory Actions”. As well we present new research results for cardioprotective effects of relaxin-2.

Join us to discuss with leading scientists from around the world, learn latest news from the relaxinologists …

The conference takes place at Coast Canmore Hotel and Conference Centre, Canmore, Alberta, Canada September 17 – 21, 2023.

The post 9th International Conference on Relaxin and Related Peptides appeared first on Relaxera.

Interview Digital Health TV 2022

Marion Michaelis — Tue, 18 Oct 2022 09:40:15 +0000

Two interviews with the Bavarian Health Management GmbH in Germany about “Relaxin and Heart Failure” and “Relaxin and Transplantation Medicine”.

Prof. Andreas Grün is interviewing Prof. Dr. Thomas B. Dschietzig, CEO Relaxera.
(in German language)

interview 1 – Relaxin and heart failure; get the summary here.

interview 2 – Relaxin and transplantation medicine; get the summary here.

The post Interview Digital Health TV 2022 appeared first on Relaxera.

Presentation at European Society of Cardiology (ESC) Congress 2022 in Barcelona

Marion Michaelis — Mon, 18 Jul 2022 13:56:17 +0000

First results of our cooperation with University of Pittsburgh Medical Center, UPMC, were presented during the ESC congress 2022 in Barcelona by Prof. Dr. Guy Salama in the session

“HFpEF and HFmrEF: what’s new in treatment” – “The therapeutic potential of relaxin for heart failure with preserved ejection fraction”

You will learn about relaxin-2 – Wnt1-interaction and gain insight into relaxin’s pleitropic actions and its ability to reverse maladaptive remodeling of atrial tissue and suppress fibrosis.
Read the abstract here.

The post Presentation at European Society of Cardiology (ESC) Congress 2022 in Barcelona appeared first on Relaxera.